Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug:76:103734.
doi: 10.1016/j.breast.2024.103734. Epub 2024 Apr 18.

The impact of age on physical functioning after treatment for breast cancer, as measured by patient-reported outcome measures: A systematic review

V R Robins  1 , S Gelcich  2 , K Absolom  3 , G Velikova  4
Affiliations

The impact of age on physical functioning after treatment for breast cancer, as measured by patient-reported outcome measures: A systematic review

V R Robins et al. Breast. 2024 Aug.

Abstract

Purpose: This systematic review aims to explore the impact of age on physical functioning post-treatment for early-stage, locally advanced, or locally recurrent breast cancer, as measured by patient-reported outcome measures (PROMs), identify PROMs used and variations in physical functioning terms/labels.

Methods: MEDLINE, EmBase, PsycINFO, CINAHL and AMED were searched, along with relevant key journals and reference lists. Risk of bias (quality) assessment was conducted using a Critical Appraisal Skills Programme checklist. Data was synthesised through tables and narrative.

Results: 28,207 titles were extracted from electronic databases, resulting in 44 studies with age sub-groups, and 120 without age sub-groups. Of those with findings on the impact of age, there was variability in the way findings were reported and 21 % found that age did not have a significant impact. However, 66 % of the studies found that with older age, physical functioning declined post-treatment. Comorbidities were associated with physical functioning declines. However, findings from sub-groups (breast cancer stage, treatment type and time post-treatment) lacked concordance. Twenty-eight types of PROM were used: the EORTC QLQ-C30 was most common (50.6 %), followed by the SF-36 (32.3 %). There were 145 terms/labels for physical functioning: 'physical functioning/function' was used most often (82.3 %).

Conclusions: Findings point towards an older age and comorbidities being associated with more physical functioning declines. However, it was not possible to determine if stage, treatment type and time since treatment had any influence. More consistent use of the terminology 'physical functioning/function' would aid future comparisons of study results.

Keywords: Age; Breast cancer; Patient reported outcomes; Physical functioning.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest Professor Galina Velikova has the following conflicts of interest: Honoraria: Pfizer, Novartis, Eisai. Advisory boards: Consultancy fees from AstraZeneca, Roche, Novartis, Pfizer, Seagen, Eisai, Sanofi. Institutional grant from Pfizer.

Figures

Fig. 1
Fig. 1
Diagram of systematic review screening process, adapted from the PRISMA (2009) flow diagram [50].
See this image and copyright information in PMC

References

    1. Yeo W., Pang E., Liem G.S., Suen J.J.S., Ng R.Y.W., Yip C.C.H., Li L., Yip C.W., et al. Menopausal symptoms in relationship to breast cancer-specific quality of life after adjuvant cytotoxic treatment in young breast cancer survivors. Health Qual Life Outcome. 2020;18(1):24. doi: 10.1186/s12955-020-1283-x. - DOI - PMC - PubMed
    1. Schreier A.M., Johnson L.A., Vohra N.A., Muzaffar M., Kyle B. Post-treatment symptoms of Pain, Anxiety, Sleep Disturbance, and Fatigue in breast cancer survivors. Pain Manag Nurs. 2019;20(2):146–151. doi: 10.1016/j.pmn.2018.09.005. - DOI - PubMed
    1. Jefford M., Rowland J., Grunfeld E., Richards M., Maher J., Glaser A. Implementing improved post-treatment care for cancer survivors in England, with reflections from Australia, Canada and the USA. Br J Cancer. 2013;108(1):14–20. doi: 10.1038/bjc.2012.554. - DOI - PMC - PubMed
    1. Maddams J., Utley M., Moller H. Projections of cancer prevalence in the United Kingdom, 2010-2040. Br J Cancer. 2012;107(7):1195–1202. doi: 10.1038/bjc.2012.366. - DOI - PMC - PubMed
    1. Cardoso F., Kyriakides S., Ohno S., Penault-Llorca F., Poortmans P., Rubio I.T., Zackrisson S., Senkus E., on behalf of the ESMO Guidelines Committee Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2019;30(8):1194–1220. doi: 10.1093/annonc/mdz173. - DOI - PubMed

Publication types